Clinical overview of venous thromboembolism

  • G Schellack
  • T Modau Sefako Makgatho Health Sciences University
  • N Schellack Sefako Makgatho Health Sciences University
Keywords: anticoagulants, deep vein thrombosis, embolus, NOAC, pulmonary embolism, thromboprophylaxis, thrombus, venous thromboembolism, Virchow’s triad

Abstract

Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE through a variety of factors, require adequate thromboprophylaxis. Primary and secondary prevention, as well as the definitive treatment of VTE, are accomplished through the use of a variety of anticoagulant drugs. This article attempts to provide an overview of VTE, and its prevention and treatment.

Author Biographies

G Schellack

Clinical research industry, South Africa

T Modau, Sefako Makgatho Health Sciences University

Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South Africa

N Schellack, Sefako Makgatho Health Sciences University

Department of Pharmacy, Faculty of Health Sciences, Sefako Makgatho Health Sciences University, South Africa

Published
2020-12-11
Section
Reviews